Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

    Diabetes Care Date published:

  • Effect of voluntary Health Star Rating labels on healthier food purchasing in New Zealand: longitudinal evidence using representative household purchase data

    BMJ Nutrition, Prevention & Health Date published:

  • Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis

    Heart Date published:

  • The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review

    Humanities and Social Sciences Communications Date published:

  • Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

    Journal of the American Heart Association Date published:

  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    The Lancet Diabetes & Endocrinology Date published:

  • Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)

    Diabetes Care Date published:

  • Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension - the SaltSwitch Online Grocery Shopping (OGS) randomised trial

    American Heart Journal Date published:

  • 19-OR: KidneyIntelX Association with Clinical Outcomes in Diabetic Kidney Disease

    Diabetes Date published:

  • Mechanisms of action of the SGLT2 inhibitor canagliflozin on tubular inflammation and damage: a post-hoc mediation analysis of the CANVAS trial

    Diabetes, Obesity and Metabolism Date published:

  • A Post Hoc Analysis of KidneyIntelX TM and Cardiorenal Outcomes in Diabetic Kidney Disease

    Kidney360 Date published:

  • Canagliflozin and Atrial Fibrillation in Type 2 Diabetes Mellitus: A secondary analysis from the CANVAS Program and CREDENCE trials and meta-analysis

    Diabetes, Obesity and Metabolism Date published:

  • 2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

    Journal of Human Hypertension Date published:

  • Sodium-glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 diabetes: A Meta-analysis of Individual Participant Data from Randomized Controlled Trials

    Circulation Date published:

  • Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE

    International Journal of Cardiology Date published:

  • Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS)

    Circulation Date published: